Characterisation of the long-term effects of anthracycline-associated myocardial toxicity using cardiac MRI; a pilot study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1532-429X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Characterisation of the long-term effects of anthracycline-associated myocardial toxicity using cardiac MRI; a pilot study ; volume:11 ; number:1 ; day:28 ; month:1 ; year:2009 ; pages:1-316 ; date:1.2009
Journal of cardiovascular magnetic resonance ; 11, Heft 1 (28.1.2009), 1-316, 1.2009
- Urheber
-
Hughes, Marina L.
- Beteiligte Personen und Organisationen
-
Bailliard, Frederique
Taylor, Andrew
Levitt, Gill
SpringerLink (Online service)
- DOI
-
10.1186/1532-429X-11-S1-P95
- URN
-
urn:nbn:de:1111-2016032159689
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hughes, Marina L.
- Bailliard, Frederique
- Taylor, Andrew
- Levitt, Gill
- SpringerLink (Online service)
Ähnliche Objekte (12)
Anthracycline‑Induced Cardiac Toxicity: A Clinical Review
Improved MRI T2 relaxometry for myocardial tissue characterisation
Ischaemic Preconditioning Protects Cardiomyocytes from Anthracycline-Induced Toxicity via the PI3K Pathway
Case report: Myocardial tuberculosis-MRI
Anthracycline Chemotherapy and Cardiotoxicity
Myocardial tissue characterisation using echocardiographic deformation imaging
Metabolic Aspects of Anthracycline Cardiotoxicity
Cardioprotection strategies for anthracycline cardiotoxicity
MRI characterization of myocardial and microvascular injuries
Motion compensated reconstruction for myocardial perfusion MRI
Characterisation of carbon nanotubes in the context of toxicity studies
Novel Anthracycline Utorubicin for Cancer Therapy
Anthracycline‑Induced Cardiac Toxicity: A Clinical Review
Improved MRI T2 relaxometry for myocardial tissue characterisation
Ischaemic Preconditioning Protects Cardiomyocytes from Anthracycline-Induced Toxicity via the PI3K Pathway
Case report: Myocardial tuberculosis-MRI
Anthracycline Chemotherapy and Cardiotoxicity
Myocardial tissue characterisation using echocardiographic deformation imaging
Metabolic Aspects of Anthracycline Cardiotoxicity
Cardioprotection strategies for anthracycline cardiotoxicity
MRI characterization of myocardial and microvascular injuries
Motion compensated reconstruction for myocardial perfusion MRI
Characterisation of carbon nanotubes in the context of toxicity studies
Novel Anthracycline Utorubicin for Cancer Therapy
Anthracycline‑Induced Cardiac Toxicity: A Clinical Review
Improved MRI T2 relaxometry for myocardial tissue characterisation
Ischaemic Preconditioning Protects Cardiomyocytes from Anthracycline-Induced Toxicity via the PI3K Pathway
Case report: Myocardial tuberculosis-MRI
Anthracycline Chemotherapy and Cardiotoxicity
Myocardial tissue characterisation using echocardiographic deformation imaging
Metabolic Aspects of Anthracycline Cardiotoxicity
Cardioprotection strategies for anthracycline cardiotoxicity
MRI characterization of myocardial and microvascular injuries
Motion compensated reconstruction for myocardial perfusion MRI
Characterisation of carbon nanotubes in the context of toxicity studies